A novel drug, retatrutide, is creating considerable anticipation in the field of obesity treatment . This two-pronged injectable approach works by imitating the effects of two gut hormones, GLP-1 and GIP, which inherently regulate food intake and encourage feelings of contentment. Early clinical inv